BrainsWay Ltd.
IPOBrainsWay Deep TMS - Innovative, Noninvasive Treatment
Public · Jerusalem, Israel · Founded 2003 · $8.5M raised
- Headquarters
- Jerusalem
- Employees
- 51–200
- Founded
- 2003
- Business Model
- B2B
- Website
- brainsway.com
- Total Funding
- $8.5M
- Last Round
- $8.5M Venture RoundNov 2022
- Rounds
- 1
- Type
- Public
About
BrainsWay develops Deep TMS technology for noninvasive treatment of mental health disorders including depression, OCD, and smoking addiction.
Summary
BrainsWay Ltd. is a Biotech company based in Jerusalem, Israel, founded in 2003. It has raised $8.5M in total across 1 round, most recently a $8.5M Venture Round round in Nov 2022. Investors include Valor Equity Partners.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...